PMCB
PharmaCyte Biotech Inc.
Company Overview
| Mkt Cap | $6.66M | Price | $0.93 |
| Volume | 23.57K | Change | -0.87% |
| P/E Ratio | 0.2 | Open | $0.94 |
| Revenue | -- | Prev Close | $0.94 |
| Net Income | $30.7M | 52W Range | $0.80 - $1.94 |
| Div Yield | N/A | Target | -- |
| Overall | 44 | Value | 80 |
| Quality | 28 | Technical | 25 |
No chart data available
Stock Overview
Updated DailyPharmaCyte Biotech Inc. (PMCB) is a leading Healthcare company in the Biotechnology industry, currently trading at $0.93 with a market capitalization of $6.66 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 28.
Today's trading session shows PMCB with a volume of 24K shares. The stock opened down 0.00% from yesterday's close of $0.94. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
PMCB demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including PAHC, USNA, NATR, MTEX.
Key investment considerations for PMCB include below-average investment characteristics. The company offers a dividend yield of NA%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 02:02 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PMCB | $0.93 | -0.9% | 23.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |